SCHEMBL3858654

SCHEMBL3858654

Cc1c(N=C2C=CC(=N)C=C2N)c(=O)n(-c2ccccc2)n1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 12/20 0.61
▸ ALDH1A1 P00352 9/20 0.61
▸ GAA P10253 8/20 0.61
▸ MAPK1 P28482 5/20 0.61
▸ MEN1 O00255 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ MPI P34949 3/20 0.61
▸ KDM4E B2RXH2 3/20 0.61
▸ HTT P42858 3/20 0.61
▸ POLB P06746 3/20 0.61
▸ MITF O75030 1/20 0.61
▸ NSD2 O96028 1/20 0.61
▸ OPRK1 P41145 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ THRB P10828 2/20 0.56
▸ BLM P54132 1/20 0.56
▸ LMNA P02545 2/20 0.55
▸ ATM Q13315 1/20 0.55
▸ TP53 P04637 1/20 0.53
▸ HSP90AA1 P07900 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3859698 1.00 MAPT (0.61) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3858650 1.00 MAPT (0.61) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3859871 0.85 MAPT (0.59) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3859873 0.85 MAPT (0.59) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3932865 0.84 MAPT (0.58) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL13963965 0.84 MAPT (0.58) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3932868 0.84 MAPT (0.58) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL3853099 0.82 MAPT (0.53) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL13924392 0.82 MAPT (0.53) MAPTALDH1A1GAAMAPK1MEN1
SCHEMBL13924407 0.82 MAPT (0.53) MAPTALDH1A1GAAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
EP-2011787-A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety L'Oreal (FR) 2009-01-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit KRT18, KMO, TMPO MAPT 308/4885ALDH1A1 729/4885GAA 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback